This suggests that SC79 increased the phosphorylation of AKT and mTOR in MED19 knocked down HCC cells, thus further supporting the hypothesis that the AKT/mTOR pathway is the molecular target of MED19 in HCC cells. This evidence concerns the gene AKT1 and hepatocellular carcinoma.